Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

From Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids Metabolism.

Castillo RI, Rojo LE, Henriquez-Henriquez M, Silva H, Maturana A, Villar MJ, Fuentes M, Gaspar PA.

Front Neurosci. 2016 Nov 8;10:488. Review.

2.

Astaxanthin and Docosahexaenoic Acid Reverse the Toxicity of the Maxi-K (BK) Channel Antagonist Mycotoxin Penitrem A.

Goda AA, Naguib KM, Mohamed MM, Amra HA, Nada SA, Abdel-Ghaffar AB, Gissendanner CR, El Sayed KA.

Mar Drugs. 2016 Nov 9;14(11). pii: E208.

4.

Prader-Willi syndrome mental health research strategy workshop proceedings: the state of the science and future directions.

Schwartz L, Holland A, Dykens E, Strong T, Roof E, Bohonowych J.

Orphanet J Rare Dis. 2016 Sep 29;11(1):131. Review.

5.

Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder?

Föcking M, Dicker P, Lopez LM, Cannon M, Schäfer MR, McGorry PD, Smesny S, Cotter DR, Amminger GP.

BMC Psychiatry. 2016 Sep 20;16(1):326. doi: 10.1186/s12888-016-1039-7.

6.

Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers.

Clark SR, Baune BT, Schubert KO, Lavoie S, Smesny S, Rice SM, Schäfer MR, Benninger F, Feucht M, Klier CM, McGorry PD, Amminger GP.

Transl Psychiatry. 2016 Sep 20;6(9):e897. doi: 10.1038/tp.2016.170.

7.

N-3 Polyunsaturated Fatty Acids through the Lifespan: Implication for Psychopathology.

Pusceddu MM, Kelly P, Stanton C, Cryan JF, Dinan TG.

Int J Neuropsychopharmacol. 2016 Dec 30;19(12). pii: pyw078. doi: 10.1093/ijnp/pyw078. Review.

8.

Attachment, Neurobiology, and Mentalizing along the Psychosis Continuum.

Debbané M, Salaminios G, Luyten P, Badoud D, Armando M, Solida Tozzi A, Fonagy P, Brent BK.

Front Hum Neurosci. 2016 Aug 22;10:406. doi: 10.3389/fnhum.2016.00406. Review.

10.

Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On Trials.

Marini S, De Berardis D, Vellante F, Santacroce R, Orsolini L, Valchera A, Girinelli G, Carano A, Fornaro M, Gambi F, Martinotti G, Di Giannantonio M.

Mediators Inflamm. 2016;2016:3476240. doi: 10.1155/2016/3476240. Review.

11.

New drug developments in psychosis: Challenges, opportunities and strategies.

Keshavan MS, Lawler AN, Nasrallah HA, Tandon R.

Prog Neurobiol. 2016 Aug 9. pii: S0301-0082(16)30075-2. doi: 10.1016/j.pneurobio.2016.07.004. [Epub ahead of print] Review.

PMID:
27519538
12.

White matter integrity in individuals at ultra-high risk for psychosis: a systematic review and discussion of the role of polyunsaturated fatty acids.

Vijayakumar N, Bartholomeusz C, Whitford T, Hermens DF, Nelson B, Rice S, Whittle S, Pantelis C, McGorry P, Schäfer MR, Amminger GP.

BMC Psychiatry. 2016 Aug 11;16(1):287. doi: 10.1186/s12888-016-0932-4.

13.

Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data.

Bozzatello P, Brignolo E, De Grandi E, Bellino S.

J Clin Med. 2016 Jul 27;5(8). pii: E67. doi: 10.3390/jcm5080067. Review.

14.

Diffusion Imaging of White Matter In Schizophrenia: Progress and Future Directions.

Karlsgodt KH.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 May;1(3):209-217.

PMID:
27453952
15.

Current understandings about cognition and the neurobiological correlates in schizophrenia.

Kar SK, Jain M.

J Neurosci Rural Pract. 2016 Jul-Sep;7(3):412-8. doi: 10.4103/0976-3147.176185. Review.

16.

An Individualized Risk Calculator for Research in Prodromal Psychosis.

Cannon TD, Yu C, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Heinssen R, Jeffries CD, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Kattan MW.

Am J Psychiatry. 2016 Oct 1;173(10):980-988.

PMID:
27363508
17.

Ethical and Epidemiological Dimensions of Labeling Psychosis Risk.

Corcoran CM.

AMA J Ethics. 2016 Jun 1;18(6):633-42. doi: 10.1001/journalofethics.2016.18.6.msoc2-1606. Review.

18.

Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review.

Trépanier MO, Hopperton KE, Mizrahi R, Mechawar N, Bazinet RP.

Mol Psychiatry. 2016 Aug;21(8):1009-26. doi: 10.1038/mp.2016.90. Review.

19.

Meta-analysis of erythrocyte polyunsaturated fatty acid biostatus in bipolar disorder.

McNamara RK, Welge JA.

Bipolar Disord. 2016 May;18(3):300-6. doi: 10.1111/bdi.12386.

PMID:
27087497
20.

Relationship between Erythrocyte Fatty Acid Composition and Psychopathology in the Vienna Omega-3 Study.

Kim SW, Jhon M, Kim JM, Smesny S, Rice S, Berk M, Klier CM, McGorry PD, Schäfer MR, Amminger GP.

PLoS One. 2016 Mar 10;11(3):e0151417. doi: 10.1371/journal.pone.0151417.

Supplemental Content

Support Center